Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Irritable Bowel Syndrome with Constipation Drugs Market Portraiture
2.1.1. Global Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2017 (US$ Mn)
2.1.2. Global Irritable Bowel Syndrome with Constipation Drugs Market, by Prescription Type, 2017 (US$ Mn)
2.1.3. Global Irritable Bowel Syndrome with Constipation Drugs Market Share, by Geography, 2017 vs. 2026 (Value %)
Chapter 3. Global Irritable Bowel Syndrome with Constipation Drugs Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Irritable Bowel Syndrome with Constipation Drugs: Future Trends
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Adverse effects on health of various dietary habits
3.3.1.2. Strong clinical pipeline with several first-in-class molecules
3.3.2. Restraints
3.3.2.1. Stringent FDA regulations
3.3.2.2. High level of ignorance among the patients
3.3.3. Opportunities
3.3.3.1. Emerging APAC Market
3.3.3.2. High Unmet needs
3.4. Attractive Investment Proposition, by Geography, 2017
3.5. Competitive Landscape, by Key Players, 2017
Chapter 4. Global Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Lubiprostone
4.3. Linaclotide
4.4. Stimulant Laxatives- Bisacodyl
4.5. Osmotic Laxatives
4.5.1. Lactulose
4.5.2. Polyethylene Glycol
4.6. Pipeline Drugs
4.6.1. Plecanatide – Pre registration
4.6.2. Tenapanor- Phase II
4.6.3. SYN-010 – Phase II
4.6.4. Relenopride – Phase II
Chapter 5. Global Irritable Bowel Syndrome with Constipation Drugs Market, by Prescription Type, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Prescription Drugs
5.3. Over the Counter Drugs
Chapter 6. Global Irritable Bowel Syndrome with Constipation Drugs Market, by Geography, 2016-2026 (US$ Mn)
6.1. Overview
6.2. North America Irritable Bowel Syndrome with Constipation Drugs Market Analysis, 2016-2026 (US$ Mn)
6.2.1. North America Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2016-2026 (US$ Mn)
6.2.2. North America Irritable Bowel Syndrome with Constipation Drugs Market, by Prescription Type, 2016-2026 (US$ Mn)
6.2.3. North America Irritable Bowel Syndrome with Constipation Drugs Market, by Country, 2016-2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Irritable Bowel Syndrome with Constipation Drugs Market Analysis, 2016-2026 (US$ Mn)
6.3.1. Europe Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2016-2026 (US$ Mn)
6.3.2. Europe Irritable Bowel Syndrome with Constipation Drugs Market, by Prescription Type, 2016-2026 (US$ Mn)
6.3.3. Europe Irritable Bowel Syndrome with Constipation Drugs Market, by Country, 2016-2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market Analysis, 2016-2026 (US$ Mn)
6.4.1. Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2016-2026 (US$ Mn)
6.4.2. Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market, by Prescription Type, 2016-2026 (US$ Mn)
6.4.3. Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market, by Country, 2016-2026 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America Irritable Bowel Syndrome with Constipation Drugs Market Analysis, 2016-2026 (US$ Mn)
6.5.1. Latin America Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2016-2026 (US$ Mn)
6.5.2. Latin America Irritable Bowel Syndrome with Constipation Drugs Market, by Prescription Type, 2016-2026 (US$ Mn)
6.6. Middle East & Africa (MEA) Irritable Bowel Syndrome with Constipation Drugs Market Analysis, 2016-2026 (US$ Mn)
6.6.1. MEA Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2016-2026 (US$ Mn)
6.6.2. MEA Irritable Bowel Syndrome with Constipation Drugs Market, by Prescription Type, 2016-2026 (US$ Mn)
Chapter 7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Ardelyx, Inc.
7.3. Astellas Pharma Inc.
7.4. AstraZeneca Plc.
7.5. Bayer AG
7.6. Fresenius Kabi AG
7.7. Ironwood Pharmaceuticals, Inc.
7.8. Sanofi S.A.
7.9. SK Biopharmaceuticals Co., Ltd.
7.10. Sucampo AG
7.11. Synergy Pharmaceuticals, Inc.
7.12. Synthetic Biologics, Inc.
List of Figures
FIG. 1 Irritable Bowel Syndrome with Constipation Drugs: Market Segmentation
FIG. 2 Attractive Investment Proposition, by Geography, 2016
FIG. 3 Competitive Landscape, by Key Players, 2016
FIG. 4 Global Lubiprostone Market in Irritable Bowel Syndrome with Constipation Drugs, 2016-2026 (US$ Mn)
FIG. 5 Global Linaclotide Market in Irritable Bowel Syndrome with Constipation Drugs, 2016-2026 (US$ Mn)
FIG. 6 Global Stimulant Laxatives-Bisacodyl Market in Irritable Bowel Syndrome with Constipation Drugs, 2016-2026 (US$ Mn)
FIG. 7 Global Lactulose Market in Irritable Bowel Syndrome with Constipation Drugs, 2016-2026 (US$ Mn)
FIG. 8 Global Polyethylene Glycol Market in Irritable Bowel Syndrome with Constipation Drugs, 2016-2026 (US$ Mn)
FIG. 9 Global Prescription Drugs Market in Irritable Bowel Syndrome with Constipation Drugs , 2016-2026 (US$ Mn)
FIG. 10 Global Over the Counter Drugs Market in Irritable Bowel Syndrome with Constipation Drugs , 2016-2026 (US$ Mn)
FIG. 11 U.S. Irritable Bowel Syndrome with Constipation Drugs Market, 2016-2026 (US$ Mn)
FIG. 12 Canada Irritable Bowel Syndrome with Constipation Drugs Market, 2016-2026 (US$ Mn)
FIG. 13 U.K. Irritable Bowel Syndrome with Constipation Drugs Market, 2016-2026 (US$ Mn)
FIG. 14 Germany Irritable Bowel Syndrome with Constipation Drugs Market, 2016-2026 (US$ Mn)
FIG. 15 Rest Of Europe Irritable Bowel Syndrome with Constipation Drugs Market, 2016-2026 (US$ Mn)
FIG. 16 Japan Irritable Bowel Syndrome with Constipation Drugs Market, 2016-2026 (US$ Mn)
FIG. 17 China Irritable Bowel Syndrome with Constipation Drugs Market, 2016-2026 (US$ Mn)
FIG. 18 Rest Of Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market, 2016-2026 (US$ Mn)
List of Tables
TABLE 1 Global Irritable Bowel Syndrome with Constipation Drugs Market Portraiture
TABLE 2 Global Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2016-2026 (US$ Mn)
TABLE 3 Global Irritable Bowel Syndrome with Constipation Drugs Market, by Prescription Type, 2016-2026 (US$ Mn)
TABLE 4 Global Irritable Bowel Syndrome with Constipation Drugs Market Share, by Geography, 2016-2026 (Value %)
TABLE 5 North America Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2016-2026 (US$ Mn)
TABLE 6 North America Irritable Bowel Syndrome with Constipation Drugs Market, by Prescription Type, 2016-2026 (US$ Mn)
TABLE 7 North America Irritable Bowel Syndrome with Constipation Drugs Market, by Country, 2016-2026 (US$ Mn)
TABLE 8 Europe Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2016-2026 (US$ Mn)
TABLE 9 Europe Irritable Bowel Syndrome with Constipation Drugs Market, by Prescription Type, 2016-2026 (US$ Mn)
TABLE 10 Europe Irritable Bowel Syndrome with Constipation Drugs Market, by Country, 2016-2026 (US$ Mn)
TABLE 11 Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2016-2026 (US$ Mn)
TABLE 12 Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market, by Prescription Type, 2016-2026 (US$ Mn)
TABLE 13 Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market, by Country, 2016-2026 (US$ Mn)
TABLE 14 Latin America Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2016-2026 (US$ Mn)
TABLE 15 Latin America Irritable Bowel Syndrome with Constipation Drugs Market, by Prescription Type, 2016-2026 (US$ Mn)
TABLE 16 Middle East And Africa Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2016-2026 (US$ Mn)
TABLE 17 Middle East And Africa Irritable Bowel Syndrome with Constipation Drugs Market, by Prescription Type, 2016-2026 (US$ Mn)
TABLE 18 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 Ardelyx, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Astellas Pharma Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 AstraZeneca Plc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Fresenius Kabi AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Ironwood Pharmaceuticals, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Sanofi S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 SK Biopharmaceuticals Co., Ltd. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Sucampo A.G.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Synergy Pharmaceuticals, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Synthetic Biologics, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)